Board meeting scheduled for May 22, 2026 to approve audited standalone and consolidated financial results for Q4 and FY ending March 31, 2026.
Board will consider recommending dividend on equity shares for financial year 2025-26 if any.
Trading window closure for designated persons extended until May 24, 2026, 48 hours after results declaration.